UBS AM’s Solventum SOLV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$25M Sell
324,368
-447,506
-58% -$32.6M ﹤0.01% 846
2026
Q1
$50.4M Buy
771,874
+44,979
+6% +$3.34M 0.01% 621
2025
Q4
$57.6M Sell
726,895
-48,257
-6% -$3.7M 0.01% 584
2025
Q3
$56.6M Sell
775,152
-286,498
-27% -$21M 0.01% 585
2025
Q2
$80.5M Sell
1,061,650
-47,473
-4% -$3.36M 0.02% 581
2025
Q1
$84.3M Buy
1,109,123
+2,929
+0.3% +$218K 0.02% 580
2024
Q4
$73.1M Buy
1,106,194
+52,423
+5% +$3.67M 0.02% 583
2024
Q3
$73.5M Buy
1,053,771
+3,745
+0.4% +$225K 0.02% 590
2024
Q2
$55.5M Buy
+1,050,026
New +$63.7M 0.02% 591

Other funds holding SOLV

UBS AM's SOLV Position: Q2 2026 in Review

UBS AM reduced its Solventum (SOLV) stake by 58% in Q2 2026, selling an estimated $32.6M and leaving 324,368 shares worth $25M. The position accounts for ﹤0.01% of the portfolio, ranked #846.

UBS AM first reported a position in SOLV in Q2 2024 and has held it in 9 quarters since. The position peaked at $84.3M in Q1 2025. 875 funds tracked by Wall St. Rank hold SOLV as of Q2 2026.

  • UBS AM held 324,368 shares of Solventum worth $25M as of Q2 2026.
  • UBS AM sold 447,506 Solventum shares in Q2 2026, an estimated $32.6M.
  • Solventum made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #846 holding.
  • UBS AM first reported a position in Solventum in Q2 2024 and has held it in 9 quarters since.
  • UBS AM's Solventum position peaked at $84.3M in Q1 2025.
  • 875 funds tracked by Wall St. Rank held Solventum as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.